Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 24 May 1985:
Vol. 228. no. 4702, pp. 996 - 999
DOI: 10.1126/science.2988126
Prev | Table of Contents | Next

Articles

Science, Vol 228, Issue 4702, 996-999
Copyright © 1985 by American Association for the Advancement of Science

articles

Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum

WR Ballou, J Rothbard, RA Wirtz, DM Gordon, JS Williams, RW Gore, I Schneider, MR Hollingdale, RL Beaudoin, WL Maloy, and al. et

In a study of recombinant proteins that might be useful in developing a vaccine against malaria, synthetic peptides from the circumsporozoite (CS) protein of Plasmodium falciparum were found to be immunogenic for mice and rabbits. Antibody to peptides from the repeating region of the CS protein recognized native CS protein and blocked sporozoite invasion of human hepatoma cells in vitro. Antibodies to peptides from regions I and II had no biologic activity, although antibody to region I recognized processed CS protein by Western blot analysis. These data support the feasibility of developing a vaccine against the sporozoite stage of the malaria parasite by using synthetic peptides of the repeating region of the CS protein conjugated to a carrier protein.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Two Decades of Commitment to Malaria Vaccine Development: GlaxoSmithKline Biologicals.
W. R. Ballou and C. P. Cahill (2007)
Am J Trop Med Hyg 77, 289-295
   Abstract »    Full Text »    PDF »
Phase I Testing of a Malaria Vaccine Composed of Hepatitis B Virus Core Particles Expressing Plasmodium falciparum Circumsporozoite Epitopes.
E. H. Nardin, G. A. Oliveira, J. M. Calvo-Calle, K. Wetzel, C. Maier, A. J. Birkett, P. Sarpotdar, M. L. Corado, G. B. Thornton, and A. Schmidt (2004)
Infect. Immun. 72, 6519-6527
   Abstract »    Full Text »    PDF »
Antibodies against Thrombospondin-Related Anonymous Protein Do Not Inhibit Plasmodium Sporozoite Infectivity In Vivo.
S. Gantt, C. Persson, K. Rose, A. J. Birkett, R. Abagyan, and V. Nussenzweig (2000)
Infect. Immun. 68, 3667-3673
   Abstract »    Full Text »    PDF »
Induction of Protective Immune Responses by Immunization with Linear Multiepitope Peptides Based on Conserved Sequences from Plasmodium falciparum Antigens.
A. Bharadwaj, P. Sharma, S. K. Joshi, B. Singh, and V. S. Chauhan (1998)
Infect. Immun. 66, 3232-3241
   Abstract »    Full Text »    PDF »
A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine against Plasmodium falciparum Malaria.
J. A. Stoute, M. Slaoui, D. G. Heppner, P. Momin, K. E. Kester, P. Desmons, B. T. Wellde, N. Garcon, U. Krzych, M. Marchand, et al. (1997)
N. Engl. J. Med. 336, 86-91
   Abstract »    Full Text »    PDF »
Malarial Circumsporozoite Protein Is a Novel Gene Delivery Vehicle to Primary Hepatocyte Cultures and Cultured Cells.
Z.-M. Ding, R. J. Cristiano, J. A. Roth, B. Takacs, and M. T. Kuo (1995)
J. Biol. Chem. 270, 3667-3676
   Abstract »    Full Text »    PDF »
Parasitic protozoa and helminths: biological and immunological challenges.
A. Mahmoud (1989)
Science 246, 1015-1022
   Abstract »    PDF »
Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides.
G. Lowell, W. Ballou, L. Smith, R. Wirtz, W. Zollinger, and W. Hockmeyer (1988)
Science 240, 800-802
   Abstract »    PDF »
Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.
S. Hoffman, C. Oster, C. Plowe, G. Woollett, J. Beier, J. Chulay, R. Wirtz, M. Hollingdale, and M Mugambi (1987)
Science 237, 639-642
   Abstract »    PDF »
Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development.
J. Egan, J. Weber, W. Ballou, M. Hollingdale, W. Majarian, D. Gordon, W. Maloy, S. Hoffman, R. Wirtz, I Schneider, et al. (1987)
Science 236, 453-456
   Abstract »    PDF »
Research toward malaria vaccines.
L. Miller, R. Howard, R Carter, M. Good, V Nussenzweig, and R. Nussenzweig (1986)
Science 234, 1349-1356
   Abstract »    PDF »
Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro.
D Mazier, S Mellouk, R. Beaudoin, B Texier, P Druilhe, W Hockmeyer, J Trosper, C Paul, Y Charoenvit, J Young, et al. (1986)
Science 231, 156-159
   Abstract »    PDF »
Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax.
T. McCutchan, A. Lal, V. de la Cruz, L. Miller, W. Maloy, Y Charoenvit, R. Beaudoin, P Guerry, R Wistar Jr, S. Hoffman, et al. (1985)
Science 230, 1381-1383
   Abstract »    PDF »
Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine.
J. Young, W. Hockmeyer, M Gross, W. Ballou, R. Wirtz, J. Trosper, R. Beaudoin, M. Hollingdale, L. Miller, C. Diggs, et al. (1985)
Science 228, 958-962
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)